Parmax Pharma has informed that it enclosed a Certificate dated 3rd October, 2023 under Regulation 74 (5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 30th September 2023 received from Purva Shregistey India, Registrar and Share Transfer Agent of the company.
The above information is a part of company’s filings submitted to BSE.